Amman Bradford K.

Chief Financial OfficerVivos Therapeutics, Inc. (VVOS) · full profile →Form 4 · filed Sep 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 31, 2021Grant(A)50K$5.26$263K50K
Mar 12, 2021Grant(A)100K$7.50$750K100K
Nov 18, 2019Grant(A)17K$7.50$125K17K
Oct 22, 2018Grant(A)83K$7.50$625K83K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-021915) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about VVOS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-21-021915"
Ask your agent
Use Arkolith to summarize insider buying and selling at Vivos Therapeutics, Inc.
over the last 90 days and cite the filings.